What are the clinician trends in prescribing DOACs versus warfarin for US Medicare beneficiaries?
A significant proportion of clinicians still predominantly prescribe warfarin over DOACs to Medicare beneficiaries, highlighting a need to address barriers to DOAC adoption.
Despite the increase in DOAC use among Medicare beneficiaries, many clinicians in this study continued to use warfarin as their predominant or only anticoagulant instead of DOACs. There is a need to address barriers to the uptake of these medications to realize their potential benefits for patients.
Wheelock et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: